—HCA
— • —
$495.47
P/E
17.46
PEG
0.01
FCF Yield
—
Rev Growth YoY
+708.0% YoY
Gross Margin
8496.0%
Health Score
4/10
D/E Ratio
54.20
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, which limits company-level context. Based on the available financial data, this appears to be a company generating significant revenue growth and operating with high financial leverage. The stock is priced at $495.47, though market capitalisation data is unavailable, preventing a definitive cap-tier classification.
Financial Health
**Score: 4/10** The financial picture is deeply contradictory. On the positive side, net margins of 897% and gross margins of 8,496% suggest extraordinary profitability metrics — figures that are highly unusual and may reflect accounting anomalies, one-time items, or a very small revenue base creating outsized ratios...
Risk Assessment
- **DEBT:** Debt/equity of 54.2x is extreme by any standard, creating significant vulnerability to rising interest rates or any disruption in cash flows. - **LIQUIDITY:** Current ratio of 0.97x means the company cannot fully cover near-term obligations with current assets, raising short-term solvency concerns. - **DATA INTEGRITY:** Gross margins of 8,496% and net margins of 897% are statistically implausible for most business models and may indicate small-base distortion or non-recurring gains, undermining the reliability of margin analysis. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates negative price momentum at the technical level. - **MISSING FUNDAMENTALS:** Free cash flow, TTM Revenue, TTM Net Income, and DCF fair value are all unavailable, severely limiting the ability to conduct comprehensive fundamental analysis. ---...